Anchiano Therapeutics Ltd ADR (ANCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANCN | AMGN | VRTX | REGN | BMY |
| Company | Anchiano Therapeutics Ltd ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 81.60 | 314.82 | 430.93 | 988.00 | 45.00 |
| High | 131.20 | 321.44 | 439.26 | 988.96 | 45.17 |
| Low | 73.60 | 312.87 | 428.62 | 966.34 | 44.54 |
| Last | 75.36 | 319.00 | 437.58 | 978.33 | 44.60 |
| Change | +3.84 | +7.59 | +8.99 | -6.31 | -0.11 |
| % Change | +5.37% | +2.44% | +2.10% | -0.64% | -0.25% |
| Volume | 1,564,843 | 1,624,130 | 476,925 | 324,653 | 4,961,845 |
| 20-Day Average Volume | 4,785,015 | 2,872,616 | 1,077,126 | 450,212 | 13,981,684 |
| Previous Close | 71.52 | 311.41 | 428.59 | 984.64 | 44.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.07 | 288.80 | 407.56 | 931.24 | 45.50 |
| 20-Day Raw Stochastic | 37.68% | 94.43% | 98.31% | 89.48% | 20.43% |
| 20-Day Relative Strength | 56.58% | 68.88% | 69.37% | 60.89% | 35.95% |
| Weighted Alpha | +284.79 | +42.94 | +30.38 | +29.88 | -33.08 |
| Today's Opinion | 96% Buy | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 96% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.92% since 03/09/21 | +3.85% since 05/08/24 | +4.69% since 05/08/24 | +2.22% since 05/08/24 | +2.14% since 05/08/24 |
| Low | 4.03 on 03/10/21 | 306.32 on 05/09/24 | 416.03 on 05/09/24 | 956.76 on 05/09/24 | 43.49 on 05/09/24 |
| High | 8.20 on 03/16/21 | 321.44 on 05/15/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | -3.68% since 02/16/21 | +20.20% since 04/15/24 | +10.34% since 04/15/24 | +8.73% since 04/15/24 | -8.05% since 04/15/24 |
| Low | 2.60 on 03/04/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 8.20 on 03/16/21 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +79.77% since 12/16/20 | +10.41% since 02/15/24 | +2.85% since 02/15/24 | +2.33% since 02/15/24 | -9.78% since 02/15/24 |
| Low | 1.65 on 01/04/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 10.55 on 02/10/21 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +344.34% since 09/16/20 | +16.89% since 11/15/23 | +25.51% since 11/15/23 | +23.30% since 11/15/23 | -13.51% since 11/15/23 |
| Low | 0.91 on 10/22/20 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 785.83 on 11/16/23 | 43.33 on 05/02/24 |
| High | 10.55 on 02/10/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,948 | 167,051,216 | 110,598,944 | 108,493,528 | 90,631,640 |
| Shares Outstanding, K | 7,420 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -11,610,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -2,140,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.95 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/06/21 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.56 | 28.55 | 26.33 | 42.91 |